Transforming breath into early upper GI cancer detection
Born out of unmet clinical need, built with cutting-edge technology and guided by patient voices. Nasalyzer is developing a breathalyzer to detect gastric cancer non-invasively. Our vision is a world where non-invasive cancer detection is accessible to everyone, everywhere.
Supported by leading institutions
A Clinical Support Tool for Early Detection
Nasalyzer’s breathalyzer detects distinct biomarker patterns in exhaled breath associated with gastric cancer. Using machine learning classifiers, it accurately identifies at-risk breath profiles. The compact device is designed for seamless integration into GP clinics and community healthcare settings.
NON - INVASIVE
Needle-free. Just a breath sample.
IMMEDIATE RESULTS
Results during consultation – not weeks later.
EASY TO USE
Designed for routine GP workflows.
Breath - Smell - Detect
Step 1: Sample
Patients provide a breath sample using our specialized breath collection device.
Step 2: Analysis
The system detects patterns of cancer-associated breath biomarkers in the sample.
Step 3: Results
AI-powered analysis processes the data and delivers results within minutes.
OUR MISSION
OUR TEAM
We are a multidisciplinary team of scientists, clinicians, and engineers redefining early cancer detection. Guided by a commitment to accessible diagnostics and global health equity, our mission is to deliver simple, affordable screening tools that enable earlier diagnosis and save lives.
NEWSLETTER
Subscribe to receive insights straight to your inbox